Vanilloid receptors mediate adrenergic nerve- and CGRP-containing nerve-dependent vasodilation induced by nicotine in rat mesenteric resistance arteries

Shinji Eguchi, Satoko Tezuka, Narumi Hobara, Shinji Akiyama, Yuji Kurosaki, Hiromu Kawasaki

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

1 Previous studies showed that nicotine induces adrenergic nerve-dependent vasodilation that is mediated by endogenous calcitonin gene-related peptide (CGRP) released from CGRP-containing (CGRPergic) nerves. The mechanisms underlying the nicotine-induced vasodilation were further studied. 2 Rat mesenteric vascular beds without endothelium were contracted by perfusion with Krebs solution containing methoxamine, and the perfusion pressure was measured with a pressure transducer. 3 Perfusion of nicotine (1-100 μM) for 1 min caused concentration-dependent vasodilation. Capsazepine (vanilloid receptor-1 antagonist; 1-10 μM) and ruthenium red (inhibitor of vanilloid response; 1-30 μM) concentration-dependently inhibited the nicotine-induced vasodilation without affecting the vasodilator response to exogenous CGRP. 4 Nicotine-induced vasodilation was not inhibited by treatment with 3,4-dihydroxyphenylalanine (DOPA) receptor antagonist (L-DOPA cyclohexyl ester; 0.001-10 μM), dopamine D1 receptor-selective antagonist (SCH23390; 1-10 μM), dopamine D2 receptor antagonist (haloperidol; 0.1-0.5 μM), ATP P2x receptor-desensitizing agonist (α,β-methylene ATP; 1-10 μM), adenosine A 2 receptor antagonist (8(p-sulfophenyl)theophylline; 10-50 μM) or neuropeptide Y (NPY)-Y1 receptor antagonist (BIBP3226; 0.1-0.5 μM). 5 Immunohistochemical staining of the mesenteric artery showed dense innervation of CGRP- and vanilloid receptor-1-positive nerves, with both immunostainings appearing in the same neuron. The mesenteric artery was also densely innervated by NPY-positive nerves. Double immunostainings showed that both NPY and CGRP immunoreactivities appeared in the same neuron of the artery. 6 These results suggest that nicotine acts on presynaptic nicotinic receptors to release adrenergic neurotransmitter(s) or related substance(s), which then stimulate vanilloid receptor-1 on CGRPergic nerves, resulting in CGRP release and vasodilation.

Original languageEnglish
Pages (from-to)1137-1146
Number of pages10
JournalBritish Journal of Pharmacology
Volume142
Issue number7
DOIs
Publication statusPublished - Aug 2004

Fingerprint

TRPV Cation Channels
Mesenteric Arteries
Calcitonin Gene-Related Peptide
Nicotine
Vasodilation
Adrenergic Agents
Dihydroxyphenylalanine
Perfusion
Neuropeptide Y
Calcitonin Gene-Related Peptide Receptors
Methoxamine
Pressure Transducers
Purinergic P2 Receptors
Presynaptic Receptors
Neurons
Ruthenium Red
Dopamine D1 Receptors
Nicotinic Receptors
Haloperidol
Vasodilator Agents

Keywords

  • Adrenergic nerves
  • Calcitonin gene-related peptide-containing nerves
  • Nicotine
  • Nicotinic receptor
  • Rat mesenteric resistance artery
  • Vanilloid receptor-1
  • Vasodilation

ASJC Scopus subject areas

  • Pharmacology

Cite this

Vanilloid receptors mediate adrenergic nerve- and CGRP-containing nerve-dependent vasodilation induced by nicotine in rat mesenteric resistance arteries. / Eguchi, Shinji; Tezuka, Satoko; Hobara, Narumi; Akiyama, Shinji; Kurosaki, Yuji; Kawasaki, Hiromu.

In: British Journal of Pharmacology, Vol. 142, No. 7, 08.2004, p. 1137-1146.

Research output: Contribution to journalArticle

Eguchi, Shinji ; Tezuka, Satoko ; Hobara, Narumi ; Akiyama, Shinji ; Kurosaki, Yuji ; Kawasaki, Hiromu. / Vanilloid receptors mediate adrenergic nerve- and CGRP-containing nerve-dependent vasodilation induced by nicotine in rat mesenteric resistance arteries. In: British Journal of Pharmacology. 2004 ; Vol. 142, No. 7. pp. 1137-1146.
@article{73d0974e10ab4c3c8bbf10a14738b921,
title = "Vanilloid receptors mediate adrenergic nerve- and CGRP-containing nerve-dependent vasodilation induced by nicotine in rat mesenteric resistance arteries",
abstract = "1 Previous studies showed that nicotine induces adrenergic nerve-dependent vasodilation that is mediated by endogenous calcitonin gene-related peptide (CGRP) released from CGRP-containing (CGRPergic) nerves. The mechanisms underlying the nicotine-induced vasodilation were further studied. 2 Rat mesenteric vascular beds without endothelium were contracted by perfusion with Krebs solution containing methoxamine, and the perfusion pressure was measured with a pressure transducer. 3 Perfusion of nicotine (1-100 μM) for 1 min caused concentration-dependent vasodilation. Capsazepine (vanilloid receptor-1 antagonist; 1-10 μM) and ruthenium red (inhibitor of vanilloid response; 1-30 μM) concentration-dependently inhibited the nicotine-induced vasodilation without affecting the vasodilator response to exogenous CGRP. 4 Nicotine-induced vasodilation was not inhibited by treatment with 3,4-dihydroxyphenylalanine (DOPA) receptor antagonist (L-DOPA cyclohexyl ester; 0.001-10 μM), dopamine D1 receptor-selective antagonist (SCH23390; 1-10 μM), dopamine D2 receptor antagonist (haloperidol; 0.1-0.5 μM), ATP P2x receptor-desensitizing agonist (α,β-methylene ATP; 1-10 μM), adenosine A 2 receptor antagonist (8(p-sulfophenyl)theophylline; 10-50 μM) or neuropeptide Y (NPY)-Y1 receptor antagonist (BIBP3226; 0.1-0.5 μM). 5 Immunohistochemical staining of the mesenteric artery showed dense innervation of CGRP- and vanilloid receptor-1-positive nerves, with both immunostainings appearing in the same neuron. The mesenteric artery was also densely innervated by NPY-positive nerves. Double immunostainings showed that both NPY and CGRP immunoreactivities appeared in the same neuron of the artery. 6 These results suggest that nicotine acts on presynaptic nicotinic receptors to release adrenergic neurotransmitter(s) or related substance(s), which then stimulate vanilloid receptor-1 on CGRPergic nerves, resulting in CGRP release and vasodilation.",
keywords = "Adrenergic nerves, Calcitonin gene-related peptide-containing nerves, Nicotine, Nicotinic receptor, Rat mesenteric resistance artery, Vanilloid receptor-1, Vasodilation",
author = "Shinji Eguchi and Satoko Tezuka and Narumi Hobara and Shinji Akiyama and Yuji Kurosaki and Hiromu Kawasaki",
year = "2004",
month = "8",
doi = "10.1038/sj.bjp.0705773",
language = "English",
volume = "142",
pages = "1137--1146",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Vanilloid receptors mediate adrenergic nerve- and CGRP-containing nerve-dependent vasodilation induced by nicotine in rat mesenteric resistance arteries

AU - Eguchi, Shinji

AU - Tezuka, Satoko

AU - Hobara, Narumi

AU - Akiyama, Shinji

AU - Kurosaki, Yuji

AU - Kawasaki, Hiromu

PY - 2004/8

Y1 - 2004/8

N2 - 1 Previous studies showed that nicotine induces adrenergic nerve-dependent vasodilation that is mediated by endogenous calcitonin gene-related peptide (CGRP) released from CGRP-containing (CGRPergic) nerves. The mechanisms underlying the nicotine-induced vasodilation were further studied. 2 Rat mesenteric vascular beds without endothelium were contracted by perfusion with Krebs solution containing methoxamine, and the perfusion pressure was measured with a pressure transducer. 3 Perfusion of nicotine (1-100 μM) for 1 min caused concentration-dependent vasodilation. Capsazepine (vanilloid receptor-1 antagonist; 1-10 μM) and ruthenium red (inhibitor of vanilloid response; 1-30 μM) concentration-dependently inhibited the nicotine-induced vasodilation without affecting the vasodilator response to exogenous CGRP. 4 Nicotine-induced vasodilation was not inhibited by treatment with 3,4-dihydroxyphenylalanine (DOPA) receptor antagonist (L-DOPA cyclohexyl ester; 0.001-10 μM), dopamine D1 receptor-selective antagonist (SCH23390; 1-10 μM), dopamine D2 receptor antagonist (haloperidol; 0.1-0.5 μM), ATP P2x receptor-desensitizing agonist (α,β-methylene ATP; 1-10 μM), adenosine A 2 receptor antagonist (8(p-sulfophenyl)theophylline; 10-50 μM) or neuropeptide Y (NPY)-Y1 receptor antagonist (BIBP3226; 0.1-0.5 μM). 5 Immunohistochemical staining of the mesenteric artery showed dense innervation of CGRP- and vanilloid receptor-1-positive nerves, with both immunostainings appearing in the same neuron. The mesenteric artery was also densely innervated by NPY-positive nerves. Double immunostainings showed that both NPY and CGRP immunoreactivities appeared in the same neuron of the artery. 6 These results suggest that nicotine acts on presynaptic nicotinic receptors to release adrenergic neurotransmitter(s) or related substance(s), which then stimulate vanilloid receptor-1 on CGRPergic nerves, resulting in CGRP release and vasodilation.

AB - 1 Previous studies showed that nicotine induces adrenergic nerve-dependent vasodilation that is mediated by endogenous calcitonin gene-related peptide (CGRP) released from CGRP-containing (CGRPergic) nerves. The mechanisms underlying the nicotine-induced vasodilation were further studied. 2 Rat mesenteric vascular beds without endothelium were contracted by perfusion with Krebs solution containing methoxamine, and the perfusion pressure was measured with a pressure transducer. 3 Perfusion of nicotine (1-100 μM) for 1 min caused concentration-dependent vasodilation. Capsazepine (vanilloid receptor-1 antagonist; 1-10 μM) and ruthenium red (inhibitor of vanilloid response; 1-30 μM) concentration-dependently inhibited the nicotine-induced vasodilation without affecting the vasodilator response to exogenous CGRP. 4 Nicotine-induced vasodilation was not inhibited by treatment with 3,4-dihydroxyphenylalanine (DOPA) receptor antagonist (L-DOPA cyclohexyl ester; 0.001-10 μM), dopamine D1 receptor-selective antagonist (SCH23390; 1-10 μM), dopamine D2 receptor antagonist (haloperidol; 0.1-0.5 μM), ATP P2x receptor-desensitizing agonist (α,β-methylene ATP; 1-10 μM), adenosine A 2 receptor antagonist (8(p-sulfophenyl)theophylline; 10-50 μM) or neuropeptide Y (NPY)-Y1 receptor antagonist (BIBP3226; 0.1-0.5 μM). 5 Immunohistochemical staining of the mesenteric artery showed dense innervation of CGRP- and vanilloid receptor-1-positive nerves, with both immunostainings appearing in the same neuron. The mesenteric artery was also densely innervated by NPY-positive nerves. Double immunostainings showed that both NPY and CGRP immunoreactivities appeared in the same neuron of the artery. 6 These results suggest that nicotine acts on presynaptic nicotinic receptors to release adrenergic neurotransmitter(s) or related substance(s), which then stimulate vanilloid receptor-1 on CGRPergic nerves, resulting in CGRP release and vasodilation.

KW - Adrenergic nerves

KW - Calcitonin gene-related peptide-containing nerves

KW - Nicotine

KW - Nicotinic receptor

KW - Rat mesenteric resistance artery

KW - Vanilloid receptor-1

KW - Vasodilation

UR - http://www.scopus.com/inward/record.url?scp=4143060252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4143060252&partnerID=8YFLogxK

U2 - 10.1038/sj.bjp.0705773

DO - 10.1038/sj.bjp.0705773

M3 - Article

VL - 142

SP - 1137

EP - 1146

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 7

ER -